Einfach Bitcoin kaufen: Mit dem Code "FINANZEN" sparen Sie 21% der Gebühren für 6 Monate bei Coinfinity. Jetzt loslegen -w-
05.04.2018 14:41:00

Alligator Bioscience Presents at the H.C. Wainwright Annual Global Life Sciences Conference

LUND, Sweden, April 5, 2018 /PRNewswire/ – Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, announced today that it will be featured as a presenting company at the H.C. Wainwright Annual Global Life Sciences Conference. The conference is being held on April 8-10 at the Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco.

CEO Per Norlén will provide an overview of the Company's business during the live presentation and will be available to participate in one-on-one meetings with investors who are registered to attend the conference.

Event: Company presentation at H.C. Wainwright Annual Global Life Sciences Conference
Date: 10 April, 2018 
Time:3:25-3:50 pm CEST
Location: Salon Atlantic-W (2nd Floor); Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco

The presentation will be webcasted live. To access the webcast, please use the direct link http://www.wsw.com/webcast/hcw2/atorx or visit www.hcwevents.com. The webcast replay will remain available for 90 days following the live presentation.

For further information, please contact:
Cecilia Hofvander,
Director Investor Relations & Communications
Phone +46-46-286-44-95
E-mail: cecilia.hofvander@alligatorbioscience.com  

The information was submitted for publication, through the agency of the contact person set out above, at 2:00 p.m. CEST on 5 April 2018.

About Alligator Bioscience

Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Alligator's growing pipeline includes four lead clinical and pre-clinical drug candidates (ADC-1013, ATOR-1015, ATOR-1017 and ALG.APV-527).

ADC-1013 (JNJ-7107) is licensed to Janssen Biotech, Inc., part of J&J, for global development and commercialization. Alligator's shares are listed on Nasdaq Stockholm (ATORX). The Company is headquartered in Lund, Sweden, and has approximately 50 employees. For more information, please visit www.alligatorbioscience.com.

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/alligator-bioscience/r/alligator-bioscience-presents-at-the-h-c--wainwright-annual-global-life-sciences-conference,c2488318

The following files are available for download:

http://mb.cision.com/Main/12681/2488318/816546.pdf

Alligator Bioscience presents at the H.C. Wainwright Annual Global Life Sciences Conference

Nachrichten zu Alligator Bioscience ABmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Alligator Bioscience ABmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Alligator Bioscience AB 0,04 -28,75% Alligator Bioscience AB